Genetic Test Evaluation

understanding how genetic tests impact patient management

The Genetic Test Evaluation program is a compilation of evidence-based assessments of genetic tests that provide clinicians with a clear,
objective view of the science behind genetic tests, the clinical evidence supporting them, and the use of these tests in clinical practice.

View a sampling of our GTE program.

SelectMDx for Prostate Cancer (MDxHealth Inc.)

March 21, 2019 Genetic Test Evaluation

This report evaluates the analytical validity, clinical validity, and clinical utility of the SelectMDx for Prostate Cancer test.

ConfirmMDx for Prostate Cancer (MDxHealth Inc.)

February 27, 2019 Genetic Test Evaluation

The report evaluates the analytical validity, clinical validity, and clinical utility of the ConfirmMDx test.

MicroGenDX (MicroGen Diagnostics LLC)

February 22, 2019 Genetic Test Evaluation

This synopsis reviews abstracts from the peer-reviewed literature base for MicroGenDX (MicroGen Diagnostics LLC).

ThyroSeq v3 (University of Pittsburgh Medical Center, CBLPath Inc.)

February 8, 2019 Genetic Test Evaluation

This synopsis reviews abstracts from the peer-reviewed literature base for ThyroSeq v3 (University of Pittsburgh Medical Center, CBLPath Inc.)

Tempus xT (Tempus Labs Inc.)

January 30, 2019 Genetic Test Evaluation

This synopsis reviews the peer-reviewed literature for Tempus xT (Tempus Labs Inc.).